News

Filter

Amgen's US deal with Servier cleared

13-08-2013

USA-based Amgen (Nasdaq: AMGN), the world's leading independent biotech firm, and privately-held French…

AmgenBiotechnologyCardio-vascularLicensingNorth AmericaPharmaceuticalProcoralanServier

Amgen gains rights to Servier's heart drugs ivabradine and S38844

10-07-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, has entered a new collaboration…

AmgenBiotechnologyCardio-vascularEuropeivabradineLicensingNorth Americaomecamtiv mecarbilPharmaceuticalS38844Servier

XOMA's perindopril and amlodipine FDC meets primary endpoint in Ph III blood pressure trial

23-11-2012

California, USA-based XOMA Corp (Nasdaq: XOMA) says the 837-patient Phase III PATH trial (Perindopril…

Amlodipine BesylateCardio-vascularLicensingNorth AmericaperindoprilPharmaceuticalResearchServierXOMA Corp

COMPANY SPOTLIGHT

Menarini

Back to top